The vaccines from Biontech / Pfizer and Moderna are said to

New Post Public Reply Private Reply Replies (2) Message Board
SamRogers
559
The vaccines from Biontech / Pfizer and Moderna are said to protect against the coronavirus for years. According to a scientific study in "Nature" magazine, they trigger a sustained immune response in the body. The results support the belief that most people immunized with the mRNA vaccines may not need a booster dose as long as the virus and its variants do not progress much beyond their current forms. However, according to the scientists involved in the study, this is not guaranteed.

"It's a good sign of how durable our immunity is after this vaccine," study leader Ali Ellebedy, immunologist at Washington University in St. Louis, told the New York Times about the results. The vaccine from Johnson & Johnson was not taken into account in the study, but he assumes that the immune response is less permanent than that of mRNA vaccines.

A month ago, a research team led by Ellebedy found that people who had survived Covid disease had immune cells against Sars-CoV-2 in the bone marrow even eight months after the infection. Another study showed that so-called memory B cells remain in the body for at least a year after infection. According to the results, researchers believe that people who were infected and later vaccinated may have a lifetime of producing immune cells against the coronavirus. However, it was unclear whether vaccination alone could have a similar long-lasting effect.

After an infection or vaccination, a specialized structure, the germinal center, forms in the lymph nodes. This structure is the basis for B cells (B lymphocytes), which form antibodies against viruses. The longer these B cells remain in the body, the more effectively they can react to virus variants. Dr. Ellebedy found that 15 weeks after the first dose of the vaccine, the germinal center was still highly active in all 14 participants and that the number of memory cells that recognized the coronavirus had not decreased.

Germ centers usually peak one to two weeks after vaccination and then decrease. "Usually there isn't much left after four to six weeks," Deepta Bhattacharya, an immunologist at the University of Arizona, told the newspaper. But the germinal centers stimulated by the mRNA vaccines barely receded months after vaccination. Most of what scientists know about the persistence of germinal centers is based on animal studies, according to Bhattacharya. The new study shows for the first time what happens to people after vaccination.

According to the study, people who are permanently treated with medication and older people with a weak immune system need a booster vaccination. According to the research group around Ellebedy, it is difficult to predict exactly how long the protection of mRNA vaccines will last. Without variants, immunity could theoretically last a lifetime. But the virus is clearly evolving.

https://www.n-tv.de/panorama/Moderna-und-Bion...50635.html

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 12

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 4

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 5

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Timur Turlov Leads FIDE with Chess and Digital Focus

Updated Category News Views 5

An Unpredicted Victory in Samarkand Well, color me surprised. Timur Turlov's made waves by clinching the role of FIDE President at the General Assembly in Samarkand. This one's quite the turn for the chess world—Kazakhstan’s own stepping up to run the whole show. This isn't just some ceremonial post either. Turlov, who's been pulling strings over at the Kazakhstan...

Continue Reading

Top 5 Most Recently Viewed Articles

Western Asset Managed Municipals Fund Announces Financial Results

Updated Category News Views 88

Western Asset Managed Municipals Fund Financial Overview Western Asset Managed Municipals Fund Inc. (NYSE: MMU) recently disclosed its financial position for the quarter ending August 31. This announcement highlights the key metrics that define the fund's performance during this period, showcasing both total assets and income earned. Current Financial Position The fund...

Continue Reading
Li Bang International Corporation Completes Successful IPO

Updated Category News Views 90

Li Bang International Corporation Celebrates IPO Milestone Li Bang International Corporation Inc. (Nasdaq: LBGJ) has officially announced the successful closing of its initial public offering (IPO), marking a significant milestone for the company. The IPO involved the sale of 1,520,000 ordinary shares at a price of $4.00 each, totaling gross proceeds of approximately...

Continue Reading
Coldstream Capital Partners: Evolution in Financial Services

Updated Category News Views 170

Coldstream Capital Partners: A New Chapter in Financial Services Coldstream has strategically rebranded its subsidiary, the Rainier Group, into Coldstream Capital Partners, marking a significant evolution in its service offerings. This change is designed to align better with the firm's commitment to expanding services, enhancing expertise, and improving operational...

Continue Reading
Nuwellis Expands Pediatric Fluid Management with Aquadex

Updated Category News Views 155

Growth in Pediatric Care through Innovative Techniques Nuwellis, Inc. (Nasdaq: NUWE), a dedicated medical technology company, has announced a significant advancement in pediatric care. A prominent children's hospital in the northeastern United States has recently adopted the Aquadex Ultrafiltration Program, a therapy designed to assist patients with cardio-renal...

Continue Reading
Valeris Innovates Patient Affordability Strategies in Healthcare

Updated Category News Views 136

Valeris Leads New Innovations in Patient Affordability Valeris, known as a comprehensive life sciences commercialization partner, is making headlines with its latest achievement in redefining patient affordability in the healthcare landscape. The Valeris Patient Affordability team is tackling the challenges posed by medical benefit maximizers, a growing concern that many...

Continue Reading